| Nome |
# |
|
The Italian multiple sclerosis register, file e3ad891f-4c9e-da0e-e053-3705fe0a2b96
|
2.395
|
|
Hypoxanthine and purine compounds in plasma from patients with multiple sclerosis and psoriasis, file e3ad8916-7217-da0e-e053-3705fe0a2b96
|
426
|
|
Effects of immunomodulatory treatment with subcutaneous interferon beta-1a oncognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis, file e3ad8916-05d2-da0e-e053-3705fe0a2b96
|
350
|
|
A new role of CYP2R1 in Multiple Sclerosis, file e3ad891e-aca8-da0e-e053-3705fe0a2b96
|
346
|
|
Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study., file e3ad8916-003f-da0e-e053-3705fe0a2b96
|
342
|
|
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases., file e3ad8916-edeb-da0e-e053-3705fe0a2b96
|
319
|
|
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis, file e3ad8916-0398-da0e-e053-3705fe0a2b96
|
289
|
|
Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab: Evidence From an Italian Spontaneous, Prospective, and Observational Study (the TY-STOP Study)., file e3ad8918-7f3b-da0e-e053-3705fe0a2b96
|
277
|
|
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone., file e3ad8916-05d1-da0e-e053-3705fe0a2b96
|
275
|
|
Four cases of progressive multifocal leukoencephalopathy in iatrogenic immunocompromised patients, file e3ad8922-20df-da0e-e053-3705fe0a2b96
|
269
|
|
Predictors of definite Multiple Sclerosis in patients with pediatric onset first demyelinating clinical attack, file e3ad8916-eec5-da0e-e053-3705fe0a2b96
|
251
|
|
Neuronavigation-guided biopsy for differential diagnosis of
pseudotumoral demyelinating brain lesions, file e3ad8916-db26-da0e-e053-3705fe0a2b96
|
189
|
|
Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: A cohort study, file e3ad891d-261a-da0e-e053-3705fe0a2b96
|
185
|
|
NEURODEGENERATION IN MULTIPLE SCLEROSIS: COMPARISON BETWEEN CLINICAL, NEUROPSYCHOLOGICAL, MRI,AND OPTICAL COHERENCE TOMOGRAPHY PARAMETERS, file e3ad8918-3bdf-da0e-e053-3705fe0a2b96
|
180
|
|
Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study, file e3ad8916-d82c-da0e-e053-3705fe0a2b96
|
158
|
|
Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study., file e3ad8916-067a-da0e-e053-3705fe0a2b96
|
147
|
|
Cathodal Occipital tDCS is unable to modulate The Sound Induced Flash Illusion in migraine, file e3ad891f-22e8-da0e-e053-3705fe0a2b96
|
145
|
|
Fumo, caffè e rischio di Sclerosi Multipla: uno studio caso-controllo, file e3ad891e-2a12-da0e-e053-3705fe0a2b96
|
137
|
|
The still under-investigated role of cognitive deficits in PML diagnosis., file e3ad891f-4ee2-da0e-e053-3705fe0a2b96
|
136
|
|
Cardiovascular comorbidity in multiple sclerosis patients treated with mitoxantrone therapy: a cohort study, file e3ad891f-150a-da0e-e053-3705fe0a2b96
|
135
|
|
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial, file e3ad891f-77b4-da0e-e053-3705fe0a2b96
|
133
|
|
Differences in intercellular communication during clinical relapse and gadolinium-enhanced MRI in patients with relapsing remitting multiple sclerosis: A study of the composition of extracellular vesicles in cerebrospinal fluid, file e3ad891e-44d6-da0e-e053-3705fe0a2b96
|
126
|
|
Klotho and vitamin D in multiple sclerosis: an Italian study, file e3ad8922-23da-da0e-e053-3705fe0a2b96
|
120
|
|
Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers, file e3ad8919-2575-da0e-e053-3705fe0a2b96
|
119
|
|
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience, file e3ad891f-7975-da0e-e053-3705fe0a2b96
|
111
|
|
Toxic effects on astrocytes of extracellular vesicles from CSF of multiple sclerosis patients: A pilot in vitro study, file e3ad8924-2dc2-da0e-e053-3705fe0a2b96
|
94
|
|
Fast one-step liquid chromatography determination of purine compounds in blood with photodiode array detector, file e3ad8916-64c3-da0e-e053-3705fe0a2b96
|
92
|
|
Lactate Threshold Training Program on Patients with Multiple Sclerosis: A Multidisciplinary Approach, file e3ad8927-7238-da0e-e053-3705fe0a2b96
|
88
|
|
The Role of Nutritional Lifestyle and Physical Activity in Multiple Sclerosis Pathogenesis and Management: A Narrative Review, file 00010298-856c-42a8-a275-bdf5ed98254f
|
76
|
|
Extracellular vesicles from CS fluid are possible biomarkers of multiple sclerosis disease status, file e3ad891d-9fce-da0e-e053-3705fe0a2b96
|
74
|
|
Foxp3 and gata3 polymorphisms, vitamin d3 and multiple sclerosis, file e3ad8927-182b-da0e-e053-3705fe0a2b96
|
73
|
|
Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection, file e686abb0-3aa4-49e5-8cce-e28fab640e91
|
71
|
|
Nutrition, physical activity, and other lifestyle factors in the prevention of cognitive decline and dementia, file e3ad8928-22ba-da0e-e053-3705fe0a2b96
|
55
|
|
Clinical features, disease course and prognosis in patients with paediatric and young adult onset multiple sclerosis, file e3ad8916-8e48-da0e-e053-3705fe0a2b96
|
49
|
|
Impact of treatment with dimethyl fumarate on sleep quality in patients with relapsing-remitting multiple sclerosis: A multicentre Italian wearable tracker study, file 9a830b07-4db2-4807-9620-44b384bdb8d1
|
39
|
|
Moral Cognition and Multiple Sclerosis: A Neuropsychological Study, file e3ad891f-7971-da0e-e053-3705fe0a2b96
|
27
|
|
Zymographic Analysis of Matrix Metalloproteinases (MMP-2 and MMP-9) in Cerebrospinal Fluid and Sera from Patients with Multiple Sclerosis, file f8bd90a3-1bf9-482b-8474-7e68bd3aaf04
|
27
|
|
Role of Multiple Vitamin D-Related Polymorphisms in Multiple Sclerosis Severity: Preliminary Findings, file ae6cbb61-aa7c-4fa9-a1cd-1d6566d1f9ac
|
26
|
|
A Brief Overview on BDNF-Trk Pathway in the Nervous System: A Potential Biomarker or Possible Target in Treatment of Multiple Sclerosis?, file f8bc1a1b-74ba-4231-b44c-ff60de839f70
|
24
|
|
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register, file e269b74c-a425-4a21-8ec7-9b2e8e139666
|
15
|
|
Four cases of progressive multifocal leukoencephalopathy in iatrogenic immunocompromised patients, file e3ad8922-70bd-da0e-e053-3705fe0a2b96
|
13
|
|
Stroke incidence and case fatality: a 9-year prospective population-based study in an elderly population of Bagheria, Italy, file 278b756d-3b0a-4483-99ab-543c9f504a5c
|
12
|
|
Off-Adherence Keeping (OAK) observational study: intentional off-adherence immunomodulatory multiple sclerosis treatment, file 821bb7dd-a2c7-4390-8752-ac280d8cb0fd
|
12
|
|
Association of CYP2R1 rs10766197 with MS risk and disease progression, file e3ad891b-d2e8-da0e-e053-3705fe0a2b96
|
12
|
|
Microchimerism in multiple sclerosis: The association between sex of offspring and MRI features in women with multiple sclerosis, file 88d9ccc3-4bbe-4e0f-9f55-f6431f45b163
|
11
|
|
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis, file 9158a65f-009b-4b58-b9a4-3ee15558b8f7
|
11
|
|
Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study, file e3ad8916-ede4-da0e-e053-3705fe0a2b96
|
11
|
|
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies, file ff65e7e6-0f42-4167-8820-854411b431b5
|
10
|
|
The HLA locus and multiple sclerosis in Sicily, file e3ad8915-e01b-da0e-e053-3705fe0a2b96
|
9
|
|
Quantitative EEG differentiates multiple sclerosis with and without cognitive impairment from healthy controls at the beginning of the disease: preliminary data, file e3ad8920-d319-da0e-e053-3705fe0a2b96
|
8
|
|
Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register, file e3ad8922-6dd7-da0e-e053-3705fe0a2b96
|
8
|
|
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis, file 192876e6-223f-44dc-8fb9-6e35f1de1106
|
6
|
|
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience, file 5ce12a96-2a7a-41b0-a183-0d25f0522794
|
6
|
|
Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register, file dc0d72a9-15b5-4ca7-b26b-2976afcab7a2
|
6
|
|
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis, file e3ad891f-7973-da0e-e053-3705fe0a2b96
|
6
|
|
Tocilizumab treatment in MOGAD: a case report and literature review, file 92a28f31-bcc4-44c0-9b5f-c174120739ea
|
5
|
|
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis, file 837e574c-3a6e-4d49-99a8-7cfd8449fce6
|
4
|
|
Modulation of action tremor by repetitive transcranial magnetic stimulation in multiple sclerosis patients, file e3ad8918-94cd-da0e-e053-3705fe0a2b96
|
4
|
|
Population-based case-control study of essential tremor, file e3ad8919-dbef-da0e-e053-3705fe0a2b96
|
4
|
|
Motor cortex tRNS improves pain, affective and cognitive impairment in patients with fibromyalgia: Preliminary results of a randomised sham-controlled trial, file e3ad891b-99ea-da0e-e053-3705fe0a2b96
|
4
|
|
NEURODEGENERATION IN MULTIPLE SCLEROSIS: COMPARISON BETWEEN CLINICAL, NEUROPSYCHOLOGICAL, MRI,AND OPTICAL COHERENCE TOMOGRAPHY PARAMETERS, file e3ad891c-7371-da0e-e053-3705fe0a2b96
|
4
|
|
Quantitative EEG differentiate Multiple Sclerosis with and without Cognitive Impairment from healthy controls at the beginning of the disease: preliminary data, file e3ad891d-dfe1-da0e-e053-3705fe0a2b96
|
4
|
|
Application of tRNS to improve multiple sclerosis fatigue: a pilot, single-blind, sham-controlled study, file e3ad891f-550b-da0e-e053-3705fe0a2b96
|
4
|
|
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML, file e3ad891f-77b6-da0e-e053-3705fe0a2b96
|
4
|
|
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML, file e3ad891f-77b7-da0e-e053-3705fe0a2b96
|
4
|
|
To do or not to do? plasma exchange and timing of steroid administration in progressive multifocal leukoencephalopathy, file e3ad891f-77b9-da0e-e053-3705fe0a2b96
|
4
|
|
Clinical Use of κ Free Light Chains Index as a Screening Test for Multiple Sclerosis, file e3ad8920-d024-da0e-e053-3705fe0a2b96
|
4
|
|
Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis, file 09692b7c-b138-4ff5-bb1f-4e41bdb4aa04
|
3
|
|
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study, file 30429eea-0a67-4647-8bce-789d39f3fca9
|
3
|
|
Transcranial magnetic resonance-guided focused ultrasound thalamotomy as a safe treatment option in multiple sclerosis patients with essential tremor, file 4d55c782-9400-40ea-922c-8d8dfd487f4d
|
3
|
|
Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals' perspective, file 62b9afbd-b342-420b-8a0f-051de7312035
|
3
|
|
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis, file 88d04f09-61d5-403c-9d4d-534188d8713e
|
3
|
|
Orofacial Migraine and Other Idiopathic Non-Dental Facial Pain Syndromes: A Clinical Survey of a Social Orofacial Patient Group, file b3536f55-f823-4837-86ce-313fc8d91c9d
|
3
|
|
Prevalence and risk factors of post-polio syndrome in a cohort of polio survivors, file e3ad8919-bbcc-da0e-e053-3705fe0a2b96
|
3
|
|
Triiodothyronine‐Induced Shortening of Chromatin Repeat Length in Neurons Cultured in a Chemically Denned Medium, file e3ad8919-db06-da0e-e053-3705fe0a2b96
|
3
|
|
Binding of flunitrazepam to differentiating neurons cultured in a chemically defined, hormone-supplemented medium, file e3ad8919-f757-da0e-e053-3705fe0a2b96
|
3
|
|
Anodal tDCS of the swallowing motor cortex for treatment of dysphagia in multiple sclerosis: a pilot open-label study, file e3ad891e-730a-da0e-e053-3705fe0a2b96
|
3
|
|
CYP27A1, CYP24A1, and RXR-α Polymorphisms, Vitamin D, and Multiple Sclerosis: a Pilot Study, file e3ad891e-ab65-da0e-e053-3705fe0a2b96
|
3
|
|
Rates and correlates of suicidal ideation among stroke survivors: a meta-analysis, file e3ad891f-796c-da0e-e053-3705fe0a2b96
|
3
|
|
Migraine and Sport in a Physically Active Population of Students: Results of a Cross‐Sectional Study, file e3ad8923-3a4f-da0e-e053-3705fe0a2b96
|
3
|
|
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study, file 0ca634d4-d607-4582-a7ef-0fb144c2fd9c
|
2
|
|
Comparing Natural History of Early and Late Onset Pediatric Multiple Sclerosis, file 33a81085-c93b-45e9-8571-5e8fd41102a0
|
2
|
|
Extracellular vesicles from CS fluid are possible biomarkers of multiple sclerosis disease status, file 4b9fdc9e-9eab-4bde-8b27-c35fe9032011
|
2
|
|
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry, file bb075811-5991-4eca-b3f8-3b1a4cd32abc
|
2
|
|
Stroke incidence and survival in three Sicilian municipalities, file e3ad8919-b8e5-da0e-e053-3705fe0a2b96
|
2
|
|
Neuronal cell cultures: A tool for investigations in developmental neurobiology, file e3ad8919-c8e6-da0e-e053-3705fe0a2b96
|
2
|
|
Expression of synapsin I gene in primary cultures of differentiating rat cortical neurons, file e3ad8919-cbc0-da0e-e053-3705fe0a2b96
|
2
|
|
Epidemiology of multiple sclerosis in Sicily, file e3ad8919-d3af-da0e-e053-3705fe0a2b96
|
2
|
|
Prevalence of essential tremor: A door–to-door survey in terrasini, sicily, file e3ad8919-d42e-da0e-e053-3705fe0a2b96
|
2
|
|
Incidence of multiple sclerosis in Bagheria City, Sicily, Italy, file e3ad8919-d603-da0e-e053-3705fe0a2b96
|
2
|
|
Impact of sociodemographic characteristics on cognitive performance in an elderly sicilian population, file e3ad8919-d60d-da0e-e053-3705fe0a2b96
|
2
|
|
Triiodothyronine accelerates the synthesis of Synapsin I in developing neurons from fetal rat brain cultured in a synthetic medium, file e3ad8919-db08-da0e-e053-3705fe0a2b96
|
2
|
|
Apolipoprotein E genotype does not influence the progression of multiple sclerosis, file e3ad8919-dcdf-da0e-e053-3705fe0a2b96
|
2
|
|
Prevalence and incidence of multiple sclerosis in the city of Monreale, Italy, file e3ad8919-fa78-da0e-e053-3705fe0a2b96
|
2
|
|
Exclusion of the Sonic Hedgehog gene as responsible for Currarino syndrome and anorectal malformations with sacral hypodevelopment, file e3ad891a-0838-da0e-e053-3705fe0a2b96
|
2
|
|
Lack of association between ubiquitin carboxy-terminal hydrolase L1 gene polymorphism and PD, file e3ad891a-0d6b-da0e-e053-3705fe0a2b96
|
2
|
|
Intravenous gammaglobulin treatment in chronic progressive multiple sclerosis, file e3ad891a-1f77-da0e-e053-3705fe0a2b96
|
2
|
|
Door-to-door prevalence survey of epilepsy in three sicilian municipalities, file e3ad891a-1fe2-da0e-e053-3705fe0a2b96
|
2
|
|
VDBP, CYP27B1, and 25-Hydroxyvitamin D Gene Polymorphism Analyses in a Group of Sicilian Multiple Sclerosis Patients, file e3ad891a-9d7a-da0e-e053-3705fe0a2b96
|
2
|
|
Effect of extracellular vesicles from CSF of multiple sclerosis patients and healthy controls on astrocytes in culture, file e3ad891b-992a-da0e-e053-3705fe0a2b96
|
2
|
| Totale |
8.659 |